{
    "root": "700d09f5-99cc-492d-ab49-442f674d9c5d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Gabapentin"
    },
    "value": "20250509",
    "ingredients": [
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        },
        {
            "name": "COPOVIDONE K25-31",
            "code": "D9C330MD8B"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        }
    ],
    "indications": "gabapentin tablets indicated : management postherpetic neuralgia adults adjunctive therapy treatment partial onset seizures , without secondary generalization , adults pediatric patients 3 years older epilepsy",
    "contraindications": "postherpetic neuralgia ( 2.1 ) dose titrated needed dose 1800 mg/day day 1 : single 300 mg dose day 2 : 600 mg/day ( i.e . , 300 mg two times day ) day 3 : 900 mg/day ( i.e . , 300 mg three times day ) epilepsy partial onset seizures ( 2.2 ) patients 12 years age older : starting dose 300 mg three times daily ; may titrated 600 mg three times daily patients 3 11 years age : starting dose range 10 15 mg/kg/day , given three divided doses ; recommended dose patients 3 4 years age 40 mg/kg/day , given three divided doses ; recommended dose patients 5 11 years age 25 35 mg/kg/day , given three divided doses . recommended dose reached upward titration period approximately 3 days dose adjusted patients reduced renal function ( 2.3 , 2.4 )",
    "warningsAndPrecautions": "gabapentin tablets , usp supplied follows : gabapentin tablets usp , 600 mg white , biconvex , elliptical , film-coated tablets , deep break line sides debossed ‘ ’ ‘ 24 ’ either side break line one side plain side . bottles 90 ndc 65862-523-90 bottles 100 ndc 65862-523-01 bottles 500 ndc 65862-523-05 bottles 2,500 ndc 65862-523-26 gabapentin tablets usp , 800 mg white , biconvex , elliptical , film-coated tablets , deep break line sides debossed ‘ ’ ‘ 25 ’ either side break line one side plain side . bottles 90 ndc 65862-524-90 bottles 100 ndc 65862-524-01 bottles 500 ndc 65862-524-05 bottles 1,700 ndc 65862-524-31 store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "gabapentin tablets contraindicated patients demonstrated hypersensitivity ingredients .",
    "indications_original": "Gabapentin tablets are indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications_original": "Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose of 1800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures (2.2) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function (2.3 , 2.4)",
    "warningsAndPrecautions_original": "Gabapentin Tablets, USP are supplied as follows:\n                  \n                  \n                     Gabapentin Tablets USP, 600 mg are white, biconvex, elliptical, film-coated tablets, with deep break line on both sides and debossed with ‘D’ and ‘24’ on either side of the break line on one side and plain on other side.\n                  \n                          Bottles of 90                           NDC 65862-523-90         Bottles of 100                         NDC 65862-523-01         Bottles of 500                         NDC 65862-523-05         Bottles of 2,500                      NDC 65862-523-26\n                     \n                         Gabapentin Tablets USP, 800 mg are white, biconvex, elliptical, film-coated tablets, with deep break line on both sides and debossed with ‘D’ and ‘25’ on either side of the break line on one side and plain on other side.\n                              Bottles of 90                           NDC 65862-524-90         Bottles of 100                         NDC 65862-524-01         Bottles of 500                         NDC 65862-524-05         Bottles of 1,700                      NDC 65862-524-31\n                  \n                  \n                     Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "Gabapentin tablets are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}